Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Recruiting 2Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Esophageal Neoplasms 6Esophageal Squamous Cell Carcinoma 5Neoplasms 2Margins of Excision 1Esophageal Diseases 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1

Interventions

Cisplatin 14Paclitaxel 12pembrolizumab 9Fluorouracil 7Radiotherapy 6Irinotecan 5Esophagectomy 5tislelizumab 4Oxaliplatin 4Leucovorin 4Drug Therapy 4Carboplatin 4toripalimab 3Levoleucovorin 3Docetaxel 3Capecitabine 3camrelizumab 2Taxes 2Radiation 2Nivolumab 2Injections 2130-nm albumin-bound paclitaxel 2spartalizumab 1sintilimab 1palbociclib 1nimotuzumab 1nazartinib 1lenvatinib 1ivarmacitinib 1futibatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Esophagectomy × 90 days × Clear all
NCT07567716 2026-05-05

Infiltration Pattern of Locally Advanced ESCC

Shanghai Chest Hospital

Enrolling by invitation
30 enrolled
Gastrointestinal

Margins of Excision, Esophageal Squamous Cell Carcinoma, Neoplasms

NCT05357846 2026-04-30

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Sun Yat-sen University

Phase 3 Recruiting
422 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07244978 2026-04-24

Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
49 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07519486 2026-04-15

INS-ESCC-CT

Sichuan University

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07505186 2026-04-01

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡